T
ACHN

TradeWorx’s Achillion Pharmaceuticals ACHN Stock Holding History

TradeWorx’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$134K Sell
13,389
-62,657
-82% -$582K 0.18% 202
2014
Q2 		$576K Buy
+76,046
New +$303K 0.47% 56

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TradeWorx's ACHN Position: Q3 2014 in Review

TradeWorx reduced its Achillion Pharmaceuticals (ACHN) stake by 82% in Q3 2014, selling an estimated $582K and leaving 13,389 shares worth $134K. The position accounts for 0.18% of the portfolio, ranked #202.

TradeWorx first reported a position in ACHN in Q2 2014 and has held it in 2 quarters since. The position peaked at $576K in Q2 2014. 161 funds tracked by Wall St. Rank hold ACHN as of Q3 2014.

  • TradeWorx held 13,389 shares of Achillion Pharmaceuticals worth $134K as of Q3 2014.
  • TradeWorx sold 62,657 Achillion Pharmaceuticals shares in Q3 2014, an estimated $582K.
  • Achillion Pharmaceuticals made up 0.18% of TradeWorx's portfolio in Q3 2014, its #202 holding.
  • TradeWorx first reported a position in Achillion Pharmaceuticals in Q2 2014 and has held it in 2 quarters since.
  • TradeWorx's Achillion Pharmaceuticals position peaked at $576K in Q2 2014.
  • 161 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2014.

Based on TradeWorx's 13F filing for Q3 2014, filed 1 Oct 2014.